v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - Exelon - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 2,044 $ 2,174
Adjustments to reconcile net income to net cash flows provided by operating activities:    
Depreciation, amortization, and accretion 2,912 2,719
Gain on sales of assets 0 (1)
Asset disallowances, impairments and write-offs 232 0
Deferred income taxes and amortization of investment tax credits 564 293
Net fair value changes related to derivatives 0 3
Other non-cash operating activities 594 1,088
Changes in assets and liabilities:    
Accounts receivable 379 (422)
Inventories (96) (41)
Accounts payable and accrued expenses (1) 165
Collateral received, net 39 (25)
Income taxes (136) 19
Regulatory assets and liabilities, net (1,063) (390)
Pension and non-pension postretirement benefit contributions (370) (313)
Other assets and liabilities 306 (259)
Net cash flows provided by operating activities 5,404 5,010
Cash flows from investing activities    
Capital expenditures (6,799) (6,095)
Proceeds from sales of assets 0 2
Other investing activities 12 (7)
Net cash flows used in investing activities (6,787) (6,100)
Cash flows from financing activities    
Changes in short-term borrowings (178) (779)
Proceeds from short-term borrowings with maturities greater than 90 days 500 0
Issuance of long-term debt 4,425 4,925
Retirement of long-term debt (1,600) (807)
Issuance of common stock 483 173
Dividends paid on common stock (1,294) (1,212)
Proceeds from employee stock plans 37 24
Other financing activities (71) (75)
Net cash flows provided by financing activities 2,302 2,249
Increase in cash, restricted cash, and cash equivalents 919 1,159
Cash, restricted cash, and cash equivalents at beginning of period 1,201 939
Cash, restricted cash, and cash equivalents at end of period 2,120 2,098
Supplemental cash flow information    
Decrease in capital expenditures not paid (4) (12)
Decrease in PP&E related to ARO update $ (4) $ (5)